Outlook Therapeutics, Inc. - COM NEW (OTLK)

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Equity / COM NEW
Number of holders
75
Total Shares
27.4M
Shares change
+3.34M
Total reported value, excl. options
$29.6M
Value change
+$3.58M
Put/Call ratio
0
Number of buys
29
Number of sells
-28
Price
$1.08
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.